[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cencora Inc (COR)

Cencora Inc (COR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,326,140
  • Shares Outstanding, K 190,827
  • Annual Sales, $ 321,333 M
  • Annual Income, $ 1,554 M
  • EBIT $ 4,804 M
  • EBITDA $ 5,872 M
  • 60-Month Beta 0.57
  • Price/Sales 0.19
  • Price/Cash Flow 14.46
  • Price/Book 18.41

Options Overview Details

View History
  • Implied Volatility 24.95% (+1.56%)
  • Historical Volatility 31.33%
  • IV Percentile 23%
  • IV Rank 21.80%
  • IV High 39.84% on 08/04/26
  • IV Low 20.80% on 08/27/25
  • Expected Move (DTE 2) 2.47 (0.78%)
  • Put/Call Vol Ratio 0.35
  • Today's Volume 77
  • Volume Avg (30-Day) 573
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 18,085
  • Open Int (30-Day) 14,714
  • Expected Range 314.64 to 319.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $4.51
  • Number of Estimates 4
  • High Estimate $4.54
  • Low Estimate $4.40
  • Prior Year $3.84
  • Growth Rate Est. (year over year) +17.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
298.43 +6.26%
on 07/23/26
333.95 -5.05%
on 08/11/26
+9.20 (+2.99%)
since 07/17/26
3-Month
261.29 +21.36%
on 06/03/26
333.95 -5.05%
on 08/11/26
+50.93 (+19.13%)
since 05/19/26
52-Week
244.82 +29.52%
on 05/06/26
377.54 -16.01%
on 11/25/25
+22.39 (+7.60%)
since 08/19/25

Most Recent Stories

More News
Cardinal Health Earnings: Can Perfection Get Priced In Twice?

Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend.

MCK : 853.71 (-1.79%)
COR : 317.10 (+0.31%)
CAH : 234.85 (-0.06%)
Is Wall Street Bullish or Bearish on Cencora Stock?

Cencora has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.

XLV : 175.68 (+3.51%)
$SPX : 7,707.98 (+0.21%)
COR : 317.10 (+0.31%)
5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call

5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call

COR : 317.10 (+0.31%)
COR Q2 Deep Dive: Specialty Platform and MSO Growth Propel Steady Healthcare Distribution

COR Q2 Deep Dive: Specialty Platform and MSO Growth Propel Steady Healthcare Distribution

COR : 317.10 (+0.31%)
Cencora’s (NYSE:COR) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

Cencora’s (NYSE:COR) Q2 CY2026 Earnings Results: Revenue In Line With Expectations

COR : 317.10 (+0.31%)
Cencora: Fiscal Q3 Earnings Snapshot

Cencora: Fiscal Q3 Earnings Snapshot

COR : 317.10 (+0.31%)
Cencora Reports Fiscal 2026 Third Quarter Results

Revenue of $84.8 billion for the Third Quarter, a 5.1 percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $3.94 and Adjusted Diluted EPS of $4.48 ...

COR : 317.10 (+0.31%)
Cencora's Pharmaceutical Distribution Margins Still Pretending Pricing Power Exists

Barchart Research What to Expect from COR Earnings COR Generated August 4, 2026 Current Price $306.28 EPS Estimate $$4.37 Consensus Rating Strong Buy Average Move 5.64% Cencora's Pharmaceutical Distribution...

COR : 317.10 (+0.31%)
Cencora Earnings: What To Look For From COR

Cencora Earnings: What To Look For From COR

COR : 317.10 (+0.31%)
McKesson's Compounding Keeps Adding Up

McKesson posted strong fiscal 2026 results, raised guidance, boosted buybacks and its dividend, and maintains a Moderate Buy rating from analysts amid its evolving specialty business mix.

MCK : 853.71 (-1.79%)
COR : 317.10 (+0.31%)
CAH : 234.85 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa.

See More

Key Turning Points

3rd Resistance Point 332.87
2nd Resistance Point 327.69
1st Resistance Point 322.39
Last Price 317.10
1st Support Level 311.91
2nd Support Level 306.73
3rd Support Level 301.43

See More

52-Week High 377.54
Fibonacci 61.8% 326.84
Last Price 317.10
Fibonacci 50% 311.18
Fibonacci 38.2% 295.52
52-Week Low 244.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.